About US

Antigen Discovery, Inc. (formerly ImmPORT Therapeutics, Inc.) develops, manufactures and markets products, and provides services that simplify and streamline the proteomic biomarker discovery process. Scientists use our novel microarray technology to study complex biological problems including causes of disease, potential new therapies, vaccines, diagnostics, and drugs.

Our customers include the NIH, the NIAID, the CDC, pharmaceutical and biotechnology companies, universities, medical centers and research institutions.

Mission STATEMENT

Create a proteomic technology company dedicated to the success of our customers by providing world-class products and services.

Corporate Culture

We consistently embrace change as part of our growth. Antigen Discovery, Inc. operates in a collaborative and inclusive environment, in which the team is encouraged to respectfully challenge one another and contribute to the creative and scientific process.